This paper is concerned with energy-to-peak state estimation on static neural networks (SNNs) with interval time-varying delays. The objective is to design suitable delay-dependent state estimators such that the peak value of the estimation error state can be minimized for all disturbances with bounded energy. Note that the Lyapunov-Krasovskii functional (LKF) method plus proper integral inequalities provides a powerful tool in stability analysis and state estimation of delayed NNs. The main contribution of this paper lies in three points: 1) the relationship between two integral inequalities based on orthogonal and nonorthogonal polynomial sequences is disclosed. It is proven that the second-order Bessel-Legendre inequality (BLI), which is based on an orthogonal polynomial sequence, outperforms the second-order integral inequality recently established based on a nonorthogonal polynomial sequence; 2) the LKF method together with the second-order BLI is employed to derive some novel sufficient conditions such that the resulting estimation error system is globally asymptotically stable with desirable energy-to-peak performance, in which two types of time-varying delays are considered, allowing its derivative information is partly known or totally unknown; and 3) a linear-matrix-inequality-based approach is presented to design energy-to-peak state estimators for SNNs with two types of time-varying delays, whose efficiency is demonstrated via two widely studied numerical examples.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1109/TCYB.2018.2836977 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Long-Term Real-World Survival of Immunotherapy Compared to Chemotherapy for Metastatic Nonsmall Cell Lung Cancer: A Propensity Score-Matched Analysis.
Thorac Cancer
January 2025
Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Article Synopsis
- This study investigates the long-term effects of immunotherapy (IO) for patients with metastatic nonsmall cell lung cancer (mNSCLC), using data from over 10,000 patients.
- The research compared IO to standard treatments, highlighting that IO offers a modest survival benefit, with an average increase of about 3.2 months for first-line therapy and 2.7 months for second-line therapy.
- While IO shows potential to extend overall survival and delay the time to next treatment, the long-term effects are still uncertain compared to clinical trial outcomes.
Load-Balanced Dynamic SFC Migration Based on Resource Demand Prediction.
Sensors (Basel)
December 2024
School of Information and Communication Engineering, Beijing University of Posts and Telecommunications, Beijing 100876, China.
In network function virtualization, the resource demand of network services changes with network traffic. SFC migration has emerged as an effective technique for preserving the quality of service. However, one important problem that has not been addressed in prior studies is how to manage network load while maintaining service-level agreements for time-varying resource demands.
View Article and Find Full Text PDFPatterns of neuronal synchrony in higher-order networks.
Phys Life Rev
December 2024
Community Healthcare Center Dr. Adolf Drolc Maribor, Ulica talcev 9, 2000 Maribor, Slovenia; Faculty of Natural Sciences and Mathematics, University of Maribor, Koroška cesta 160, 2000 Maribor, Slovenia; Complexity Science Hub, Metternichgasse 8, 1080 Vienna, Austria; Department of Physics, Kyung Hee University, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Republic of Korea. Electronic address:
Synchrony in neuronal networks is crucial for cognitive functions, motor coordination, and various neurological disorders. While traditional research has focused on pairwise interactions between neurons, recent studies highlight the importance of higher-order interactions involving multiple neurons. Both types of interactions lead to complex synchronous spatiotemporal patterns, including the fascinating phenomenon of chimera states, where synchronized and desynchronized neuronal activity coexist.
View Article and Find Full Text PDFPredicting persistent SARS-CoV-2 shedding in immunocompromised patients: a probability-based approach.
Infect Dis (Lond)
January 2025
Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Background: Although recommended isolation periods for Coronavirus disease 2019 (COVID-19) have been shortened as the pandemic has subsided, prolonged Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) shedding remains common in immunocompromised patients. This study estimated the probability of viral clearance in these patients based on elapsed days and specific risk factors.
Methods: We prospectively enrolled immunocompromised patients with a confirmed COVID-19 diagnosis from January 2022 to May 2023 during the Omicron variant era.
Population pharmacokinetics of iruplinalkib in healthy volunteers and patients with solid tumors.
Clin Transl Sci
January 2025
Qilu Pharmaceutical Co., Ltd, Jinan, Shandong, China.
Iruplinalkib (WX-0593), a selective oral ALK/ROS1 tyrosine kinase inhibitor, was approved in China as first-line therapy for ALK-positive non-small-cell lung cancer (NSCLC) and for the treatment of locally advanced or metastatic ALK-positive NSCLC that has progressed following crizotinib therapy. Pharmacokinetics (PK) data of iruplinalkib have been collected in healthy subjects and patient populations in several studies. We developed a population PK (PopPK) model for describing iruplinalkib plasma concentrations and for evaluating whether dose adjustments are necessary based on demographic factors or disease characteristics.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!